Jayne Hornung, MMIT’s Chief Clinical Officer, has led the company’s clinical team for the past five years. Jayne maintains a sharp focus on the evolving market access landscape, especially in oncology and complex disease states. In an almost two-decade career with MMIT, Jayne’s research into drug, indication and policy data has helped hundreds of pharmaceutical clients understand market access from a clinical perspective. Prior to joining the company, Jayne worked in various positions across the healthcare and pharma industries, and once owned and operated an independent pharmacy. She graduated as a clinical pharmacist from Philadelphia College of Pharmacy in the late 1990s.
